Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Study of the Maternal-fetal Interface Prospectively to the Onset of Preeclampsia Using Single Cell Technology.

NCT06232668 is registered in ClinicalTrials.gov with Carlos Simon Foundation as lead sponsor.

NCT NCT06232668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Study of the Maternal-fetal Interface Prospectively to the Onset of Preeclampsia Using Single Cell Technology.
Lead sponsor
Carlos Simon Foundation
Phase
Observational
Overall status
Recruiting
Start date
November 20, 2023
Completion date
December 31, 2027
Enrollment
2,084 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia